Free Trial
CVE:NDVA

Indiva (NDVA) Stock Price, News & Analysis

Indiva logo
C$0.03 -0.01 (-14.29%)
As of 06/12/2024

About Indiva Stock (CVE:NDVA)

Key Stats

Today's Range
C$0.03
C$0.04
50-Day Range
C$0.03
C$0.03
52-Week Range
C$0.02
C$0.13
Volume
558,384 shs
Average Volume
119,038 shs
Market Capitalization
C$5.86 million
P/E Ratio
N/A
Dividend Yield
4.04%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NDVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indiva and its competitors with MarketBeat's FREE daily newsletter.

NDVA Stock News Headlines

Indiva Ltd (T8RP.BE) - Yahoo Finance
Indiva Ltd Average Daily Volume (3m)
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
Indiva Limited (NDVA-H.V)
NDVA:CA Indiva Limited
Indiva Limited (NDVAF) Q4 2023 Earnings Call Transcript
See More Headlines

NDVA Stock Analysis - Frequently Asked Questions

Indiva's stock was trading at C$0.03 at the beginning of the year. Since then, NDVA shares have increased by 0.0% and is now trading at C$0.03.

Shares of NDVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Indiva investors own include Meta Platforms (META), Canopy Growth (CGC), 22nd Century Group (XXII), AcelRx Pharmaceuticals (ACRX), Acasti Pharma (ACST), Curaleaf (CURLF) and Fortress Biotech (FBIO).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:NDVA
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$4.92 million
Net Margins
-13.09%
Pretax Margin
N/A
Return on Equity
-544.76%
Return on Assets
-3.51%

Debt

Debt-to-Equity Ratio
5,899.22
Current Ratio
0.72
Quick Ratio
0.52

Sales & Book Value

Annual Sales
C$37.57 million
Price / Sales
0.16
Cash Flow
C$0.01 per share
Price / Cash Flow
5.20
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
195,490,000
Free Float
N/A
Market Cap
C$5.86 million
Optionable
Not Optionable
Beta
1.12
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (CVE:NDVA) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners